Brussels halts sale of new Roche drug
Roche, the Swiss pharmaceuticals group, has suffered its third setback over new drugs in little more than a year, following a European Union decision to halt sales of Tasmar, a drug for treating
Roche, the Swiss pharmaceuticals group, has suffered its third setback over new drugs in little more than a year, following a European Union decision to halt sales of Tasmar, a drug for treating